Biotech Values

[flatlander_60048]

I think you made a good move.
While the multiples are depressed in health care (especially big pharma), yet JnJ trades as a slight premium despite these numerous lapses. I looked seriously at JnJ and NVS a few years ago and chose NVS. While NVS may perpetually trade at a discount due to its European roots (and Wall Street biases), they appear to be navigating troubled waters that better than most.

Good Luck

FL